Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 335

1.

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS.

N Engl J Med. 1999 Mar 11;340(10):764-71.

PMID:
10072411
[PubMed - indexed for MEDLINE]
Free Article
2.

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.

Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE.

N Engl J Med. 2004 Sep 30;351(14):1391-402.

PMID:
15459300
[PubMed - indexed for MEDLINE]
Free Article
3.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
[PubMed - indexed for MEDLINE]
4.

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.

Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli J, Yanovich S, Stiff P, Greenberg R, Donowitz G, Schuster M, Reboli A, Wingard J, Arndt C, Reinhardt J, Hadley S, Finberg R, Laverdière M, Perfect J, Garber G, Fioritoni G, Anaissie E, Lee J; National Institute of Allergy and Infectious Diseases Mycoses Study Group.

N Engl J Med. 2002 Jan 24;346(4):225-34. Erratum in: N Engl J Med. 2007 Feb 15;356(7):760.

PMID:
11807146
[PubMed - indexed for MEDLINE]
Free Article
5.

A safety and feasibility study comparing an intermittent high dose with a daily standard dose of liposomal amphotericin B for persistent neutropenic fever.

Ellis M, Bernsen R, Ali-Zadeh H, Kristensen J, Hedström U, Poughias L, Bresnik M, Al-Essa A, Stevens DA.

J Med Microbiol. 2009 Nov;58(Pt 11):1474-85. doi: 10.1099/jmm.0.012401-0. Epub 2009 Jul 9.

PMID:
19589901
[PubMed - indexed for MEDLINE]
Free Article
6.

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group.

Wingard JR, White MH, Anaissie E, Raffalli J, Goodman J, Arrieta A; L Amph/ABLC Collaborative Study Group.

Clin Infect Dis. 2000 Nov;31(5):1155-63. Epub 2000 Nov 7.

PMID:
11073745
[PubMed - indexed for MEDLINE]
Free Article
7.

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.

Boogaerts M, Winston DJ, Bow EJ, Garber G, Reboli AC, Schwarer AP, Novitzky N, Boehme A, Chwetzoff E, De Beule K; Itraconazole Neutropenia Study Group.

Ann Intern Med. 2001 Sep 18;135(6):412-22.

PMID:
11560454
[PubMed - indexed for MEDLINE]
8.

Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia.

White MH, Bowden RA, Sandler ES, Graham ML, Noskin GA, Wingard JR, Goldman M, van Burik JA, McCabe A, Lin JS, Gurwith M, Miller CB.

Clin Infect Dis. 1998 Aug;27(2):296-302.

PMID:
9709879
[PubMed - indexed for MEDLINE]
Free Article
9.

An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in treating invasive fungal infections or febrile neutropenia in patients with haematological malignancy.

Ellis M, Frampton C, Joseph J, Alizadeh H, Kristensen J, Hauggaard A, Shammas F.

J Med Microbiol. 2006 Oct;55(Pt 10):1357-65.

PMID:
17005784
[PubMed - indexed for MEDLINE]
Free Article
10.

[Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial].

Rieger CT, Dittmer M, Ostermann H.

Dtsch Med Wochenschr. 2007 Oct;132(40):2062-6. German.

PMID:
17899499
[PubMed - indexed for MEDLINE]
11.

A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India.

Jadhav MP, Shinde VM, Chandrakala S, Jijina F, Menon H, Arora B, Kurkure PA, Parikh PM, Kshirsagar NA.

Indian J Cancer. 2012 Jan-Mar;49(1):107-13. doi: 10.4103/0019-509X.98933.

PMID:
22842177
[PubMed - indexed for MEDLINE]
Free Article
12.

Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.

Cagnoni PJ.

J Antimicrob Chemother. 2002 Feb;49 Suppl 1:81-6. Review.

PMID:
11801587
[PubMed - indexed for MEDLINE]
Free Article
13.

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients.

Prentice HG, Hann IM, Herbrecht R, Aoun M, Kvaloy S, Catovsky D, Pinkerton CR, Schey SA, Jacobs F, Oakhill A, Stevens RF, Darbyshire PJ, Gibson BE.

Br J Haematol. 1997 Sep;98(3):711-8.

PMID:
9332329
[PubMed - indexed for MEDLINE]
14.

Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

Cordonnier C, Pautas C, Maury S, Vekhoff A, Farhat H, Suarez F, Dhédin N, Isnard F, Ades L, Kuhnowski F, Foulet F, Kuentz M, Maison P, Bretagne S, Schwarzinger M.

Clin Infect Dis. 2009 Apr 15;48(8):1042-51. doi: 10.1086/597395.

PMID:
19281327
[PubMed - indexed for MEDLINE]
Free Article
15.

Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections.

Blyth CC, Hale K, Palasanthiran P, O'Brien T, Bennett MH.

Cochrane Database Syst Rev. 2010 Feb 17;(2):CD006343. doi: 10.1002/14651858.CD006343.pub2. Review.

PMID:
20166083
[PubMed - indexed for MEDLINE]
16.

[Meta-analysis on safety and efficacy of liposomal amphotericin B in the empirical treatment of febrile neutropenia].

Badia X, Roset M, Carreras E, Ausin I, Herrera L.

Med Clin (Barc). 2004 May 1;122(16):610-6. Review. Spanish.

PMID:
15142508
[PubMed - indexed for MEDLINE]
17.

Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.

Cagnoni PJ, Walsh TJ, Prendergast MM, Bodensteiner D, Hiemenz S, Greenberg RN, Arndt CA, Schuster M, Seibel N, Yeldandi V, Tong KB.

J Clin Oncol. 2000 Jun;18(12):2476-83. Erratum in: J Clin Oncol 2000 Aug;18(16):3064.

PMID:
10856108
[PubMed - indexed for MEDLINE]
18.

A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.

Malik IA, Moid I, Aziz Z, Khan S, Suleman M.

Am J Med. 1998 Dec;105(6):478-83.

PMID:
9870832
[PubMed - indexed for MEDLINE]
19.

Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.

Subirà M, Martino R, Gómez L, Martí JM, Estany C, Sierra J.

Eur J Haematol. 2004 May;72(5):342-7.

PMID:
15059069
[PubMed - indexed for MEDLINE]
20.

Impact of alternate definitions of fever resolution on the composite endpoint in clinical trials of empirical antifungal therapy for neutropenic patients with persistent fever: analysis of results from the Caspofungin Empirical Therapy Study.

de Pauw BE, Sable CA, Walsh TJ, Lupinacci RJ, Bourque MR, Wise BA, Nguyen BY, DiNubile MJ, Teppler H.

Transpl Infect Dis. 2006 Mar;8(1):31-7.

PMID:
16623818
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk